Researcher.Life Logo

Cancer Biology and Therapy : Impact Factor & More

eISSN: 1555-8576pISSN: 1538-4047
JournalOpen Access

Key Metrics

CiteScore
8.3
Eigenfactor
0.005 - 0.01
H-Index
126
Impact Factor
< 5
SJR
Q1Oncology
SNIP
0.87
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Biology and Therapy

Cancer Biology and Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS INC
Language English
Frequency Monthly
Article Processing ChargesEUR 2710 | GBP 2335 | USD 2970
Publication Time11
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2002
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 11
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Cancer Biology and Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Biology and Therapy

Research progress on the compositional characteristics of the tumor immune microenvironment and immunopredictive models in esophageal squamous cell carcinoma
  • 31 Dec 2026
  • Cancer Biology & Therapy
Jujuboside A induces bladder cancer cell apoptosis by inhibiting ATP1A2-mediated mitochondrial energy metabolism regulation
  • 31 Dec 2026
  • Cancer Biology & Therapy
IGF2BP3 promotes gastric cancer progression by inhibiting ferroptosis through ETV4-mediated regulation of GCH1
  • 31 Dec 2026
  • Cancer Biology & Therapy
UCHL5 suppresses thyroid carcinoma progression via ZRANB1 stabilization and ferroptosis regulation
  • 31 Dec 2026
  • Cancer Biology & Therapy
Inhibition of STAT3-mediated glycolysis by bruceine D suppresses non-small-cell lung cancer progression in vitro and in vivo
  • 31 Dec 2026
  • Cancer Biology & Therapy
Centromere protein I promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR-CDK2 cascade
  • 31 Dec 2026
  • Cancer Biology & Therapy
Research progress on the compositional characteristics of the tumor immune microenvironment and immunopredictive models in esophageal squamous cell carcinoma
  • 31 Dec 2026
  • Cancer Biology & Therapy
Jujuboside A induces bladder cancer cell apoptosis by inhibiting ATP1A2-mediated mitochondrial energy metabolism regulation
  • 31 Dec 2026
  • Cancer Biology & Therapy
IGF2BP3 promotes gastric cancer progression by inhibiting ferroptosis through ETV4-mediated regulation of GCH1
  • 31 Dec 2026
  • Cancer Biology & Therapy
UCHL5 suppresses thyroid carcinoma progression via ZRANB1 stabilization and ferroptosis regulation
  • 31 Dec 2026
  • Cancer Biology & Therapy
Inhibition of STAT3-mediated glycolysis by bruceine D suppresses non-small-cell lung cancer progression in vitro and in vivo
  • 31 Dec 2026
  • Cancer Biology & Therapy
Centromere protein I promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR-CDK2 cascade
  • 31 Dec 2026
  • Cancer Biology & Therapy

FAQs on Cancer Biology and Therapy